New Book on Phenotypic and Genotypic Diagnosis of Malignancies a Must-Have for All Cancer Pathologists
Research and Markets (http://www.researchandmarkets.com/reports/c85237) has announced the addition of Phenotypic and Genotypic Diagnosis of Malignancies: An Immunohistochemical and Molecular Approach to their offering.
Carefully designed as an easy and quick reference, this desktop manual is for working pathologists who need to determine the particular type of cancer they are dealing with in a patient. To this end, the book contains many large tables of information to allow a fast analysis of results, providing all the relevant information to diagnose the full range of different tumors in humans.
Must-have content for all cancer pathologists.
Authors bio:
Dr. Muin S. A. Tuffaha obtained the honours degree in general medicine (MD) from the Medical Institute Kiev in 1986 before he passed the German Medical Board in Pathology (Facharzt). Afterwards he continued his carrier as specialist in pathology in the Institute of Pathology at the Faculty of Medicine at the Technical University of Dresden, Germany. Tuffaha was the deputy head of the Department of Head and Neck Pathology in the Faculty of Medicine at University of Hamburg, Germany before he became the Head of the Pathology Department and Director of the Laboratories in the Al-Amal Regional Cancer in Amman, Jordan from 1996 to 1998. In 2003 Tuffaha became director of the German Center of Laboratory Medicine in Amman, Jordan.
This report contains:
1 Introduction to Immunohistochemical and Molecular Methods in Tumor Diagnosis, and the Detection of Micrometastases and Circulating Tumor Cells.
2 Diagnostic Immunohistochemistry.
2.1 Introduction.
2.2 Pharmacopathology.
2.3 Immunophenotypic Profiles of Tumors.
2.4 Common Antibodies used for Tumor Diagnosis on Paraffin Sections and Expression Pattern.
2.5 Immunohistochemical Staining: Avidin–Biotin Horseradish Detection System.
3 Molecular Diagnosis of Tumors.
3.1 Introduction.
3.2 Nucleic Acids and Techniques.
3.3 Diagnosis of Tumors, Micrometastases and Circulating Tumor Cells by Molecular Detection of Specific Chromosomal Translocations.
3.4 Diagnosis of Lymphoma and Residual Tumor Cells by Molecular Detection of Gene Rearrangements.
3.5 Diagnosis of Tumors, Micrometastases, Isolated and Circulating Tumor Cells by Molecular Detection of Tissue-Specific Gene Expression.
3.6 Diagnosis of Tumors, Micrometastases, Isolated and Circulating Tumor Cells by Molecular Detection of Tissue-Specific Cytokeratins.
3.7 Molecular Detection of Tumor-Associated Viruses.
4 Classification of Malignancies and the Status of Minimal Residual Cancer Disease (an Addition to the TNM Classification).
For more information visit http://www.researchandmarkets.com/reports/c85237